Explore how BioDuro's advanced DIO (diet-induced obesity) rodent models and metabolic platforms accelerate the development of new obesity treatments. Discover predictive tools that bridge preclinical research and clinical outcomes—helping innovators tackle weight rebound, combination therapies, and metabolic mechanisms with greater confidence.

Key Highlights:

• Human-relevant models for obesity and metabolic dysfunction

• Advanced phenotyping with body composition and energy metabolism analysis

• Actionable insights into drug efficacy, rebound effects, and multi-target mechanisms

Unlock faster, more confident obesity drug development with BioDuro's integrated approach. Download the full article to explore how our platforms can advance your research!